Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Ethics and the HPV vaccine: considerations for school nurses.

Bennett MP.

J Sch Nurs. 2008 Oct;24(5):275-83. doi: 10.1177/1059840508322380.

PMID:
18941151
2.

Understanding HPV disease and prevention: a guide for school nurses.

Lockwood-Rayermann S, McIntyre SJ.

J Sch Nurs. 2009 Aug;25(4):261-9. doi: 10.1177/1059840509333787. Review.

PMID:
19363106
3.

Ethical analysis of HPV vaccine policy options.

Zimmerman RK.

Vaccine. 2006 May 29;24(22):4812-20. Review.

PMID:
16603278
4.

A proposed ethical framework for vaccine mandates: competing values and the case of HPV.

Field RI, Caplan AL.

Kennedy Inst Ethics J. 2008 Jun;18(2):111-24.

PMID:
18610781
5.

Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.

Watson M, Shaw D, Molchanoff L, McInnes C.

Aust N Z J Public Health. 2009 Aug;33(4):365-70. doi: 10.1111/j.1753-6405.2009.00409.x.

PMID:
19689598
6.

The HPV vaccine mandate controversy.

Haber G, Malow RM, Zimet GD.

J Pediatr Adolesc Gynecol. 2007 Dec;20(6):325-31. Review.

PMID:
18082853
7.

Human papillomavirus disease and vaccines.

Hutchinson DJ, Klein KC.

Am J Health Syst Pharm. 2008 Nov 15;65(22):2105-12. doi: 10.2146/ajhp070627. Review.

PMID:
18997137
8.

The human papillomavirus vaccine: an oncology nursing issue.

Buick C, Metcalfe K.

Can Oncol Nurs J. 2009 Summer;19(2):60-4.

PMID:
19757763
9.

An assessment of the readiness for introduction of the HPV vaccine in Uganda.

Katahoire RA, Jitta J, Kivumbi G, Murokora D, Arube WJ, Siu G, Arinaitwe L, Bingham A, Mugisha E, Tsu V, LaMontagne DS.

Afr J Reprod Health. 2008 Dec;12(3):159-72.

PMID:
19435020
10.

Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.

Wong LP.

J Low Genit Tract Dis. 2009 Apr;13(2):85-93. doi: 10.1097/LGT.0b013e3181865f44.

PMID:
19387128
11.

An ethical dilemma in school nursing.

Levitt E, Taylor S.

J Sch Nurs. 1999 Oct;15(4):19-24.

PMID:
10818877
12.

A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.

Dunne EF, Datta SD, E Markowitz L.

Cancer. 2008 Nov 15;113(10 Suppl):2995-3003. doi: 10.1002/cncr.23763. Review.

PMID:
18980283
13.

HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.

Castellsagué X, Schneider A, Kaufmann AM, Bosch FX.

Gynecol Oncol. 2009 Dec;115(3 Suppl):S15-23. doi: 10.1016/j.ygyno.2009.09.021.

PMID:
19819540
14.
15.

The new human papillomavirus (HPV) vaccine: pros and cons for pediatric and adolescent health.

Thomas TL.

Pediatr Nurs. 2008 Sep-Oct;34(5):429-31. Review.

PMID:
19051848
16.

Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007.

Jain N, Euler GL, Shefer A, Lu P, Yankey D, Markowitz L.

Prev Med. 2009 May;48(5):426-31. doi: 10.1016/j.ypmed.2008.11.010.

PMID:
19100762
17.

Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years.

Petäjä T, Keränen H, Karppa T, Kawa A, Lantela S, Siitari-Mattila M, Levänen H, Tocklin T, Godeaux O, Lehtinen M, Dubin G.

J Adolesc Health. 2009 Jan;44(1):33-40. doi: 10.1016/j.jadohealth.2008.10.002.

PMID:
19101456
18.

Disparities in how parents are learning about the human papillomavirus vaccine.

Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT.

Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):363-72. doi: 10.1158/1055-9965.EPI-08-0418.

PMID:
19190161
19.

Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians.

Kahn JA, Cooper HP, Vadaparampil ST, Pence BC, Weinberg AD, LoCoco SJ, Rosenthal SL.

Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2325-32. doi: 10.1158/1055-9965.EPI-09-0184.

PMID:
19661092
20.

Sociocultural issues in the introduction of human papillomavirus vaccine in low-resource settings.

Bingham A, Drake JK, LaMontagne DS.

Arch Pediatr Adolesc Med. 2009 May;163(5):455-61. doi: 10.1001/archpediatrics.2009.50.

PMID:
19414692

Supplemental Content

Support Center